Zhe Zhang

Zhe Zhang

Auto-generated profile, based on publicly available information

Zhe Zhang

Institute of Neuroscience, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai 200031, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2015 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
ZZZhe Zhang
Zhe Zhang
VFValentina Ferretti
Valentina Ferretti
IGİlke Güntan
İlke Güntan
AMAlessandro Moro
Alessandro Moro
ESEleonora A Steinberg
Eleonora A Steinberg
NFNicholas P Franks
Nicholas P Franks
The authors use TetTag pharmacogenetics to mark neuronal ensembles activated in the preoptic hypothalamus during dexmedeotomidine-induced sedation or recovery sleep. When these ensembles were selectively reactivated, NREM sleep and the accompanying drop in body temperature were recapitulated. Thus α2 adrenergic receptor–induced sedation and recovery sleep share circuitry sufficient for producing these states. Do sedatives engage natural sleep pathways? It is usually assumed that anesthetic-induced sedation and loss of righting reflex (LORR) arise by influencing the same circuitry to lesser or greater extents. For the α2 adrenergic receptor agonist dexmedetomidine, we found that sedation and LORR were in fact distinct states, requiring different brain areas: the preoptic hypothalamic area and locus coeruleus (LC), respectively. Selective knockdown of α2A adrenergic receptors from the LC abolished dexmedetomidine-induced LORR, but not sedation. Instead, we found that dexmedetomidine-induced sedation resembled the deep recovery sleep that follows sleep deprivation. We used TetTag pharmacogenetics in mice to functionally mark neurons activated in the preoptic hypothalamus during dexmedetomidine-induced sedation or recovery sleep. The neuronal ensembles could then be selectively reactivated. In both cases, non-rapid eye movement sleep, with the accompanying drop in body temperature, was recapitulated. Thus, α2 adrenergic receptor–induced sedation and recovery sleep share hypothalamic circuitry sufficient for producing these behavioral states.

7 June 2022 in Cell Metabolism
Verified
Journal Article
Closed access
CFChenzhang Feng
Chenzhang Feng
YWYing Wang
Ying Wang
XZXi Zha
Xi Zha
HCHuateng Cao
Huateng Cao
SHShajin Huang
Shajin Huang
ZZZhe Zhang
Zhe Zhang

27 July 2021 in eLife
Verified
Journal Article
Open access
CCChin-Hsuan Chia
Chin-Hsuan Chia
XTXin-Wei Tang
Xin-Wei Tang
YCYue Cao
Yue Cao
HCHua-Teng Cao
Hua-Teng Cao
WZWei Zhang
Wei Zhang
RHRui-Ping Hu
Rui-Ping Hu
Sleep is essential in maintaining physiological homeostasis in the brain. While the underlying mechanism is not fully understood, a ‘synaptic homeostasis’ theory has been proposed that synapses continue to strengthen during awake and undergo downscaling during sleep. This theory predicts that brain excitability increases with sleepiness. Here, we collected transcranial magnetic stimulation measurements in 38 subjects in a 34 hr program and decoded the relationship between cortical excitability and self-report sleepiness using advanced statistical methods. By utilizing a combination of partial least squares regression and mixed-effect models, we identified a robust pattern of excitability changes, which can quantitatively predict the degree of sleepiness. Moreover, we found that synaptic strengthen occurred in both excitatory and inhibitory connections after sleep deprivation. In sum, our study provides supportive evidence for the synaptic homeostasis theory in human sleep and clarifies the process of synaptic strength modulation during sleepiness.

22 November 2024 in Nature Methods
Verified
Journal Article
Closed access
PDF file
YZYujie Zhang
Yujie Zhang
LBLu Bai
Lu Bai
XWXin Wang
Xin Wang
YZYuchen Zhao
Yuchen Zhao
TZTianlei Zhang
Tianlei Zhang
KWKai Wang
Kai Wang

18 November 2025 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
LJLinhao Jiang
Linhao Jiang
JZJin Zhao
Jin Zhao
MXMiaoyun Xia
Miaoyun Xia
YSYifan Song
Yifan Song
HCHuateng Cao
Huateng Cao
QYQianzi Yang
Qianzi Yang
Anxiety disorders impose a substantial global burden, yet current pharmacotherapies often lack sustained efficacy and carry risks of dependence. Dexmedetomidine (Dex), a selective α2 adrenergic receptor agonist primarily used for sedation, demonstrates promising anxiolytic properties, but its long-term neural mechanisms remain unclear. Here, using a chronic restraint stress (CRS) mouse model, we reveal that tyrosine hydroxylase (TH)-positive neurons in the locus coeruleus (LC) are persistently hyperactivated during chronic anxiety states, driving elevated norepinephrine (NE) release in the medial prefrontal cortex (mPFC). A single low dose of Dex (50 µg/kg) produced anxiolytic effects lasting ≥3 days, evidenced by improved performance in open-field, light-dark box, and elevated plus maze tests. In vivo fiber photometry and chemogenetic approaches demonstrated that Dex suppresses LC-NE neuronal hyperactivity and normalizes mPFC NE levels. Crucially, neuron-specific knockdown of α2 receptors in the LC abolished Dex’s anxiolytic effects, confirming their essential role. These findings elucidate a neural mechanism wherein Dex sustains anxiety relief via α2 receptor-mediated inhibition of the LC-NE-mPFC circuit, highlighting its potential as a novel long-acting therapeutic strategy for anxiety disorders.

20 March 2025 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
YPYanmin Peng
Yanmin Peng
CFChenzhang Feng
Chenzhang Feng
SPShiyu Peng
Shiyu Peng
YWYing Wang
Ying Wang
QZQian Zhang
Qian Zhang
ZZZhe Zhang
Zhe Zhang